🇺🇸 FDA
Patent

US 12371685

PH20 polypeptide variants with a modification at position 324 of the PH20 polypeptide and a method of making thereof

granted A61KA61K38/00A61K38/28

Quick answer

US patent 12371685 (PH20 polypeptide variants with a modification at position 324 of the PH20 polypeptide and a method of making thereof) held by HALOZYME, INC. expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K38/28, A61K38/47, A61K45/06